This is of particular interest in the context of AITL since RhoA was found mutated in up to 70% of AITL patients [31] as well as in our mAITL mouse model (Supplementary Fig. 7A and B). This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.